Dermatology News & Articles

1 Risk of a Second Primary Cancer after Non-melanoma Skin Cancer in White Men and Women: A Prospective Cohort Study Full Text PLoS Medicine, May 24, 2013

2 Management of advanced non-melanoma skin cancers using helical tomotherapy Journal of the European Academy of Dermatology and Venereology, May 24, 2013    Clinical Article

3 Late Recurrence in Melanoma: Clinical Implications of Lost Dormancy Journal of the American College of Surgeons, May 24, 2013    Clinical Article

4 A costly revolution for a subgroup of patients with metastatic melanoma British Journal of Dermatology, May 24, 2013    Clinical Article

5 Anorectal and genital mucosal melanoma is associated with cutaneous melanoma in patients and in families British Journal of Dermatology, May 24, 2013    Clinical Article

6 Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10mg/kg within an expanded access programme Cancer Immunology, Immunotherapy, May 24, 2013    Clinical Article

7 Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells Pigment Cell & Melanoma Research, May 24, 2013    Clinical Article

8 Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice British Journal of Cancer, May 24, 2013    Review Article

9 Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma Journal of Clinical Oncology, May 24, 2013    Clinical Article

10 Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours British Journal of Cancer, May 24, 2013    Clinical Article

11 Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes Annals of Oncology, May 24, 2013    Clinical Article

12 Conjunctival Melanomas harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas Clinical Cancer Research, May 24, 2013    Clinical Article

13 MERTK receptor tyrosine kinase is a therapeutic target in melanoma Full Text The Journal of Clinical Investigation, May 24, 2013    Clinical Article

14 Sunbed use among subjects at high risk for melanoma: an Italian survey after the ban British Journal of Dermatology, May 24, 2013    Clinical Article

15 Carboplatin, paclitaxel and sorafenib in advanced melanoma -what have we learned? Full Text Translational Cancer Research , May 6, 2013    Clinical Article

16 Novel Targets in the Treatment of Advanced Melanoma: New First-Line Treatment Options Annals of Pharmacotherapy, May 6, 2013    Clinical Article

17 Pharmacodynamic Effects and Mechanisms of Resistance to Vemurafenib in Patients With Metastatic Melanoma Journal of Clinical Oncology, May 6, 2013    Clinical Article

18 Disease Progression and Patient Survival Are Significantly Influenced by BRAF Protein Expression in Primary Melanoma British Journal of Dermatology, May 6, 2013    Clinical Article

19 Similar efficacy for phase I trials in comparison with DTIC for advanced malignant melanoma: an analysis of melanoma outcomes in CTEP-sponsored phase I trials 1995-2011 Melanoma Research, May 6, 2013    Clinical Article

20 Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma Journal of Immunotherapy, May 6, 2013    Clinical Article

21 Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma Clinical Cancer Research, May 6, 2013    Clinical Article

22 Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: A Phase II trial (CTEP 7190/ Mel47) Clinical Cancer Research, May 6, 2013    Clinical Article

23 Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients British Journal of Dermatology, May 6, 2013    Clinical Article

24 Predicting Disease Progression After Regional Therapy for In-Transit Melanoma Disease Progression After Regional Therapy JAMA Surgery, May 6, 2013    Review Article

25 p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis Journal of Experimental Medicine, May 6, 2013    Clinical Article

26 Quality of life and comorbidity in localized malignant melanoma: results of a German population-based cohort study International Journal of Dermatology, April 19, 2013    Review Article    Clinical Article

27 Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes Archives of Dermatological Research, April 19, 2013    Clinical Article

28 A structured review of patient-reported outcome measures for patients with skin cancer, 2013 British Journal of Dermatology, April 19, 2013    Review Article

29 Increasing incidence and survival of a rare skin cancer in the Netherlands. A population-based study of 2,220 cases of skin adnexal carcinoma Journal of Surgical Oncology, April 19, 2013    Clinical Article

30 Tumor-Specific T Cells in Human Merkel Cell Carcinomas: A Possible Role for Tregs and T-Cell Exhaustion in Reducing T-Cell Responses Journal of Investigative Dermatology, April 19, 2013    Clinical Article

31 Molecular biology of normal melanocytes and melanoma cells Journal of Clinical Pathology, April 19, 2013    Review Article

32 Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma Full Text The Oncologist, April 8, 2013    Clinical Article

33 Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women Cancer, April 8, 2013    Clinical Article

34 Effect of paclitaxel/carboplatin salvage chemotherapy in noncutaneous versus cutaneous metastatic melanoma Melanoma Research, April 8, 2013    Clinical Article

35 Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis Dermatologic Therapy, April 8, 2013    Clinical Article

36 Non-melanoma skin cancer: carcinogenesis and chemoprevention Pathology, April 8, 2013    Clinical Article

37 Exposure to phototoxic NSAIDs and quinolones is associated with an increased risk of melanoma European Journal of Clinical Pharmacology, April 8, 2013    Clinical Article

38 Photosensitizing Agents and the Risk of Non-Melanoma Skin Cancer: A Population-Based Case–Control Study Journal of Investigative Dermatology, March 25, 2013    Clinical Article

39 Skin Cancer Associated With the Use of Sorafenib and Sunitinib for Renal Cell Carcinoma Dermatologic Surgery, March 25, 2013    Clinical Article

40 Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer Photodermatology, Photoimmunology and Photomedicine, March 25, 2013    Clinical Article

41 Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC British Journal of Dermatology, March 25, 2013    Clinical Article

1 Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Sham Device-Controlled Multicenter Trial Dermatologic Surgery, April 4, 2013

2 Topical treatments for cutaneous warts: an update Expert Review of Dermatology, February 11, 2013    Review Article

3 Onychomycosis Does Not Always Require Systemic Treatment for Cure: A Trial Using Topical Therapy Pediatric Dermatology, February 11, 2013

4 Efficacy of 4 weeks topical bifonazole treatment for onychomycosis after nail ablation with 40% urea: a double-blind, randomized, placebo-controlled multicenter study Mycoses, April 17, 2013

5 Psoriasis Is Not Associated with Atherosclerosis and Incident Cardiovascular Events: The Rotterdam Study Journal of Investigative Dermatology, April 15, 2013

6 Effect of vitamin D supplementation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trial British Journal of Dermatology, April 2, 2013

7 Isotretinoin 5 mg daily for low-grade adult acne vulgaris - a placebo-controlled, randomized double-blind study Journal of the European Academy of Dermatology and Venereology, April 29, 2013

8 Neuropathic itch: diagnosis and management Dermatologic Therapy, April 24, 2013    Review Article

9 Low-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris Dermatologic Therapy, April 11, 2013

10 Management of keloids and hypertrophic scars: current and emerging options Clinical, Cosmetic and Investigational Dermatology, April 25, 2013    Free full text

11 Prognostic factors that affect the response to topical treatment in patchy alopecia areata Journal of the European Academy of Dermatology and Venereology, February 21, 2013

12 Amiodarone and the risk of cancer Cancer, April 18, 2013

13 A randomized, double-blind, placebo and active-controlled, half-head study to evaluate the effects of platelet rich plasma on alopecia areata British Journal of Dermatology, April 23, 2013

14 Consensus recommendations for the treatment of basal cell carcinomas in Gorlin syndrome with topical methylaminolaevulinate-photodynamic therapy Journal of the European Academy of Dermatology and Venereology, April 16, 2013

15 TNF- antagonists and nail psoriasis: an open, 24-week, prospective cohort study in adult patients with psoriasis Expert Opinion on Biological Therapy, March 26, 2013

16 Pimecrolimus for psoriasis Expert Opinion on Pharmacotherapy, April 8, 2013

17 Topical treatments for chronic plaque psoriasis Cochrane Reviews, April 1, 2013

18 Diet-induced pigmented purpuric dermatosis Australasian Journal of Dermatology, April 12, 2013

19 Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis Dermatologic Therapy, April 2, 2013

20 Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study Journal of Dermatological Treatment , April 5, 2013